Skip to main content
Equibles
ALEC logo

ALEC · Alector, Inc. · Webcasts, Transcripts & Audio

Track ALEC — free

Use ALEC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALEC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.45 -0.18 (-6.84%) At close · Nov 12 Play latest call Q2 2025 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$364.75M
Shares
148.88M
Volume · Nov 12 1.87M Avg daily vol (3M) 3.31M

Alector, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Alector, Inc. (ALEC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Alector, Inc. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    


    
    

        

            
            
            
            
        

            

                
                    
                    
                    
                    
            

        
        
    


    
    

            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY26 · Q3

                    
2026-11-05

                


                
                

                    
Alector, Inc. (ALEC) Q3 2026 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$162.87M

▲ 4895.9% YoY                                

                                

                                    
Diluted EPS

                                    
$1.11

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Conference
                    

                        
Investor event

                    
2026-09-15

                


                
                

                    
Alector, Inc. (ALEC) September 15, 2026 Conference Transcript

                    

                    

                


                
                

                        No reported result — non-financial event
                


                
                

                    Audio
                    Transcript
                    Slides
                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY25 · Q2

                    
2025-08-07

                


                
                

                    
Alector, Inc. (ALEC) Q2 2025 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                FTD-GRN disease background and unmet need
                                AL-101 early Alzheimer's Phase 2
                                Regulatory strategy and FDA engagement
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$7.87M

▼ 47.8% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.30

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q4

                    
2025-02-26

                


                
                

                    
Alector, Inc. (ALEC) Q4 2024 Earnings Call Transcript

                    

                            
                                Positive tone
                            
                                Latozinemab Phase 3 INFRONT-3 in FTD granulin
                                Alector Brain Carrier (ABC) platform
                                AL101 in early Alzheimer's disease
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$54.23M*

▲ 256.1% YoY                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q2

                    
2024-08-07

                


                
                

                    
Alector, Inc. (ALEC) Q2 2024 Earnings Call Transcript

                    

                            
                                Confident tone
                            
                                TREM2 mechanism / microglia biology differentiation
                                INVOKE-2 Phase 2 AL002 data readout
                                Latozinemab / INFRONT-3 pivotal Phase 3 in FTD-GRN
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$15.08M

▼ 73.2% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.40

▼ 2100% YoY                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY24 · Q1

                    
2024-05-08

                


                
                

                    
Alector, Inc. (ALEC) Q1 2024 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$15.90M

▼ 3.9% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.38

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q4

                    
2024-01-16

                


                
                

                    
Alector, Inc. (ALEC) Q4 2023 Earnings Call Transcript

                    

                            
                                Positive tone
                            
                                AL002 / INVOKE-2 Phase 2 in Alzheimer's
                                AL101 / PROGRESS-AD Phase 2 in early Alzheimer's
                                Immuno-neurology / microglia mechanism
                    

                


                
                

                        

                                

                                    
Revenue

                                    
$15.23M*

▲ 5.6% YoY                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-K                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q3

                    
2023-11-07

                


                
                

                    
Alector, Inc. (ALEC) Q3 2023 Earnings Call

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$9.11M

▼ 38.7% YoY                                

                                

                                    
Diluted EPS

                                    
$-0.53

                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
            
                
                

                
                

                    

                        
                        Earnings call
                    

                        
FY23 · Q2

                    
2023-08-03

                


                
                

                    
Alector, Inc. (ALEC) Q2 2023 Earnings Call Transcript

                    

                    

                


                
                

                        

                                

                                    
Revenue

                                    
$56.21M

▼ 29.6% YoY                                

                                

                                    
Diluted EPS

                                    
$0.02

▼ 83.3% YoY                                

                                

                                    Rev · 8q
                                    Trailing quarterly revenue
                                

                        

                


                
                

                    Audio
                    Transcript
                    Slides
8-K10-Q                


                
            
    

    

        
Showing 1–9 of 9 webcasts

    

    

    
    


        

    

        

            

                Key facts
                    
                        CIK
                        1653087
                    
                    
                        CUSIP
                        014442107
                    
                    
                        13F (30d)
                        74 filings
                        59 filers
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations